ABOUT US

OVERVIEW

TEAM

Our mission is to discover, develop and deliver innovative therapeutics
for patients suffering from cancer and other incurable diseases.

  • DR. HYUNHEE KWAK CEO

    EDUCATION

    • College of Pharmacy, Seoul National University, M.S. (1990~1992), Ph.D. (2005~2010)
    • College of Pharmacy, Ewha Woman’s University, B.S. (1986-1990)

    PROFESSIONAL EXPERIENCE

    • Checkmate Therapeutics, CEO (2019~present)
    • Research Institute, Dong-A Socio Holdings, Director/Head of Biologics Res. Lab. (2015~2019)
    • Research Institute, Dong-A Pharmaceuticals, Senior Research Scientist (1992~2014)
  • DR. HYUN SEOK KIM FOUNDER & CTO

    EDUCATION

    • University of Texas Southwestern Medical Center, Postdoc (2008~2014)
    • Washington University in St. Louis, Computational Biology, Ph.D. (2003~2008)
    • Department of Microbiology, Seoul National University, B.S, M.S. (1991~1997)

    PROFESSIONAL EXPERIENCE

    • Checkmate Therapeutics, CTO (2019~present)
    • Yonsei University College of Medicine, Assistant professor, Associate professor (2014~present)
    • R&D Center of Pharmaceuticals, CJ Institute of Science & Technology, Research Scientist (1997~2003)
  • JOOYOUNG LEE BIOLOGY, DIRECTOR

    EDUCATION

    • Division of Life and Pharmaceutical Sciences, Ewha Woman’s University, M.S. (2005~2007), Ph.D. (2008~2012)
    • Department of life science, Ewha Woman’s University, B.S. (2001-2005)

    PROFESSIONAL EXPERIENCE

    • Checkmate Therapeutics, Director (2020~present)
    • Yonsei University College of Medicine, Assistant research professor (2018~2019)
    • Yonsei University College of Medicine, Postdoctal fellow (2014~2017)
  • LIM JONG WON BIOLOGY, DIRECTOR

    EDUCATION

    • Fred Hutchinson Cancer Research Center, Postdoc (2011~2018)
    • Washington University in St. Louis, Postdoc (2008-2011)
    • Washington University in St. Louis, Developmental Biology, Ph.D. (2002~2008)
    • Department of Microbiology, Seoul National University, B.S. (1994~1998)

    PROFESSIONAL EXPERIENCE

    • Checkmate Therapeutics, Director (2021~present)
    • Universal Cells (An Astellas Company), Scientist II (2018~2020)
  • SEUNGWAN KANG MEDICINAL CHEMISTRY, DIRECTOR

    EDUCATION

    • Department of Chemistry, Korea University, M.S. (2002-2004)
    • Department of Chemistry, Korea University, B.S. (1995-2002)

    PROFESSIONAL EXPERIENCE

    • Checkmate Therapeutics, Director, Head of Development Department (2020~present)
    • Drug Discovery Center, Life Sciences R&D, LG Chem, Senior Research Scientist (2017~2019)
    • Drug Discovery R&D Center, LG Life Sciences, Senior Research Scientist (2004~2016)
  • LEE SAE YEON CMC, DIRECTOR

    EDUCATION

    • Division of Science in Organic Chemistry, Hanyang University / Korea Institute of Science and Technology, Master (2005 – 2007)
    • Division of Science in Chemistry, Gachon University, B.S. (1997 – 2005)

    PROFESSIONAL EXPERIENCE

    • Checkmate Therapeutics, Director (2021~present)
    • Independent CMC consultant (2019 – 2021)
    • Nano PharmaSolutions Inc., Co-founder, Chief Operating Officer (2019 – 2021)
    • Qurient Co. Ltd., Team head of CMC development
      (2012 – 2019)
    • Institut Pasteur Korea, Researcher II (2007-2012)
  • KIM SONG WON CFO

    EDUCATION

    • Department of Business Administration, Chung Ang University, B.S (1988~1992)

    PROFESSIONAL EXPERIENCE

    • Checkmate Therapeutics, CFO (2021~present)
    • Neuracle Science, CFO (2015~2021)
    • Eyegene, CFO (2014~2015)
    • NEW, CFO (2008~2013)
    • Helixmith, Acounting Manager (2002~2007)
    • Terasource VC, Accounting Manager (2000~2001)
    • Hotel Intercontinental Seoul, Accountant (1995~2000)